ASND Competitors & Alternatives
Compare Ascendis Pharma AS with similar stocks in the same industry
Biotechnology
ASND
Main Stock$256.55
Tradestie Score
31
Market Cap
$12.36B
P/E Ratio
19.9
Revenue Growth
1.1%
Analyst Upside
+19.4%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GMAB
Genmab A/S ADS
|
$54.07
|
$19.56B | 47.7 | 32 | Compare |
|
INCY
Incyte Genomics Inc
|
$120.30
|
$16.93B | 62.2 | 53 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$69.45
|
$15.70B | 44.9 | 43 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$17.83
|
$15.22B | - | 45 | Compare |
|
EXEL
Exelixis Inc
|
$70.58
|
$11.09B | 21.5 | 32 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.19
|
$10.76B | - | 43 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$250.83
|
$10.74B | - | 48 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$57.13
|
$10.53B | - | 51 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$28.19
|
$10.49B | - | 45 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$78.67
|
$10.22B | - | 41 | Compare |
More ASND Analysis
Data updated: Nov 10, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry